Rory Wolfe

May 23, 2024 | jamanetwork.com | Rory Wolfe |Robyn L. Woods |Liubov D. Robman |Galina A. Makeyeva

Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical Trial Key PointsQuestion  Does low-dose long-term daily aspirin use affect the incidence or progression of age-related macular degeneration (AMD)?

Mar 29, 2024 | digitalcommons.library.tmc.edu | John McNeil |John Mcneil |Rory Wolfe |Robyn L. Woods |Andrew M. Tonkin

BACKGROUND: Aspirin is a well-established therapy for the secondary prevention of cardiovascular events. However, its role in the primary prevention of cardiovascular disease is unclear, especially in older persons, who have an increased risk.